Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
The Journal of Applied Laboratory Medicine
|
May 24, 2020
Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism
Lisa Ford, Adam D Kennedy, Kelli D Goodman, et al.
Nature Medicine
|
November 13, 2007
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA
Rong Wang, Kevin R Braughton, Dorothee Kretschmer, et al.
Plos One
|
September 30, 2017
Biochemical phenotyping unravels novel metabolic abnormalities and potential biomarkers associated with treatment of GLUT1 deficiency with ketogenic diet
Gerarda Cappuccio, Michele Pinelli, Marianna Alagia, et al.
Diagnostics (Basel, Switzerland)
|
January 8, 2020
Digital Microfluidic Platform to Maximize Diagnostic Tests with Low Sample Volumes from Newborns and Pediatric Patients
Rama S Sista, Rainer Ng, Miriam Nuffer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 25, 2008
Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification
Adam D Kennedy, Michael Otto, Kevin R Braughton, et al.
Frontiers in Neuroscience
|
February 22, 2020
Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis
Adam D Kennedy, Kirk L Pappan, Taraka Donti, et al.
Molecular Genetics and Metabolism
|
December 23, 2017
Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profiling
Kevin E Glinton, Paul J Benke, Matthew A Lines, et al.
Journal of Inherited Metabolic Disease
|
April 16, 2015
Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism
Marcus J Miller, Adam D Kennedy, Andrea D Eckhart, et al.
Frontiers in Neuroscience
|
May 29, 2019
2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis
Adam D Kennedy, Kirk L Pappan, Taraka Donti, et al.
Metabolites
|
March 27, 2024
Integrating Genome Sequencing and Untargeted Metabolomics in Monozygotic Twins with a Rare Complex Neurological Disorder
Rulan Shaath, Aljazi Al-Maraghi, Haytham Ali, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
The Journal of Applied Laboratory Medicine
|
May 24, 2020
Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism
Lisa Ford, Adam D Kennedy, Kelli D Goodman, et al.
Nature Medicine
|
November 13, 2007
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA
Rong Wang, Kevin R Braughton, Dorothee Kretschmer, et al.
Plos One
|
September 30, 2017
Biochemical phenotyping unravels novel metabolic abnormalities and potential biomarkers associated with treatment of GLUT1 deficiency with ketogenic diet
Gerarda Cappuccio, Michele Pinelli, Marianna Alagia, et al.
Diagnostics (Basel, Switzerland)
|
January 8, 2020
Digital Microfluidic Platform to Maximize Diagnostic Tests with Low Sample Volumes from Newborns and Pediatric Patients
Rama S Sista, Rainer Ng, Miriam Nuffer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 25, 2008
Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification
Adam D Kennedy, Michael Otto, Kevin R Braughton, et al.
Frontiers in Neuroscience
|
February 22, 2020
Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis
Adam D Kennedy, Kirk L Pappan, Taraka Donti, et al.
Molecular Genetics and Metabolism
|
December 23, 2017
Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profiling
Kevin E Glinton, Paul J Benke, Matthew A Lines, et al.
Journal of Inherited Metabolic Disease
|
April 16, 2015
Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism
Marcus J Miller, Adam D Kennedy, Andrea D Eckhart, et al.
Frontiers in Neuroscience
|
May 29, 2019
2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis
Adam D Kennedy, Kirk L Pappan, Taraka Donti, et al.
Metabolites
|
March 27, 2024
Integrating Genome Sequencing and Untargeted Metabolomics in Monozygotic Twins with a Rare Complex Neurological Disorder
Rulan Shaath, Aljazi Al-Maraghi, Haytham Ali, et al.
Page
of 7